SCHEMBL5755174

SCHEMBL5755174

CCn1c(-c2ccco2)nnc1C(S)c1noc(-c2cccc(C)c2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
SIRT1 Q96EB6 1/20 0.40
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.39
TP53 P04637 2/20 0.39
HSD17B10 Q99714 2/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
MAPT P10636 3/20 0.38
HTT P42858 1/20 0.38
NPC1 O15118 4/20 0.37
RAB9A P51151 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 4/20 0.37
PKM P14618 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1543952 0.91 MEN1 (0.43) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL1544434 0.88 ALDH1A1 (0.39) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL1543988 0.85 KCNH2 (0.45) ALDH1A1MEN1KMT2AKDM4ETP53
SCHEMBL1544075 0.84 MEN1 (0.40) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL1544718 0.82 KCNH2 (0.43) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL1544098 0.81 KCNH2 (0.47) ALDH1A1MEN1KMT2ATP53SMN1; SMN2
SCHEMBL1543663 0.81 ALDH1A1 (0.36) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL1543943 0.81 GRM5 (0.41) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL1543611 0.81 ALDH1A1 (0.37) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL1543976 0.80 KMT2A (0.42) ALDH1A1MEN1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723144-A1 ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2006-11-22 EP disclosed
WO-2006014185-A1 ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2006-02-09 WO disclosed